Frequently Asked Questions about Clinical Trials

I am a patient who is interested in getting on a trial with cabozantinib, how do I find out more information?

For additional information on participating in a clinical trial of cabozantinib, please visit ClinicalTrials.gov or contact Exelixis Medical Information at 1-888-EXELIXIS or email at druginfo@exelixis.com to find a clinical trial site in your area. In addition please speak with your physician to discuss any questions you may have regarding clinical trial participation.

I am a health care practitioner who wants to put one of my patients on a cabozantinib trial, what steps do I need to take?

Please visit ClinicalTrials.gov or contact Exelixis Medical Information at 1-888-EXELIXIS or at druginfo@exelixis.com to find a clinical trial site in your area.

How can I enroll a patient in the ongoing COMET-1 and COMET-2 phase 3 studies for castration-resistant prostate cancer (CRPC)?

For information on COMET-1 (NCT01605227) and COMET-2 (NCT01522443) and to find and contact a participating clinical trial site in your area please visit ClinicalTrials.gov or contact Exelixis Medical Information at 1-888-EXELIXIS or at druginfo@exelixis.com.

I am an investigator interested in participating in clinical trials with cabozantinib. Who do I contact?

Please contact Exelixis Medical Information at 1-888-EXELIXIS or at druginfo@exelixis.com for information about participating as an investigator in cabozantinib clinical trials.

For all other questions regarding clinical trials please contact Exelixis Medical Information at 1-888-EXELIXIS or email at druginfo@exelixis.com.